ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,918Medicare Part D Prescriptions Filled, Including Refills

Rank: 66 out of 457

$494K Total Retail Price of All Prescriptions

Rank: 124 out of 457

317 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 12,635 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
AMLODIPINE BESYLATE 574 572 1 4
LISINOPRIL 452 450 2 3
LOVASTATIN 429 429 3 25
ATENOLOL 418 418 4 11
LEVOTHYROXINE SODIUM 341 314 5 5
METFORMIN HCL 321 311 6 6
FOLIC ACID 307 307 7 81
PANTOPRAZOLE SODIUM 289 265 8 59
OMEPRAZOLE 281 262 9 1
DONEPEZIL HCL 275 275 10 22
SIMVASTATIN 267 267 11 2
RANITIDINE HCL 258 255 12 17
METOPROLOL SUCCINATE 257 255 13 21
LOSARTAN POTASSIUM 230 228 14 18
ZOLPIDEM TARTRATE 198 188 15 13
ATORVASTATIN CALCIUM 185 178 16 33
TEMAZEPAM 174 171 17 48
GLIPIZIDE 172 172 18 42
TERAZOSIN HCL 166 166 19 180
GABAPENTIN 147 138 20 15
PRILOSEC OTC 139 139 10 21 352
HYDROCHLOROTHIAZIDE 138 138 22 8
CIALIS 137 137 23 119
NAMENDA 135 135 24 32
METOPROLOL TARTRATE 134 129 25 7
CLOPIDOGREL 133 133 26 19
AMLODIPINE BESYLATE-BENAZEPRIL 133 133 26 72
FENOFIBRATE 130 125 28 46
CARVEDILOL 128 128 29 20
PLAVIX 126 126 30 24
ALPRAZOLAM 123 122 31 39
SERTRALINE HCL 122 121 32 57
BENICAR 116 116 33 90
ACTONEL 108 108 34 117
OXYBUTYNIN CHLORIDE 98 98 35 142
CRESTOR 98 98 35 9
TAMSULOSIN HCL 98 98 35 36
AZITHROMYCIN 98 95 35 44
MEGESTROL ACETATE 97 94 R 39 94
ALENDRONATE SODIUM 94 94 40 16
ISOSORBIDE MONONITRATE ER 93 93 41 84
TRAMADOL HCL 90 81 42 26
CLOTRIMAZOLE-BETAMETHASONE 90 87 42 60
NAPROXEN 87 87 44 65
FUROSEMIDE 86 86 45 10
PAROXETINE HCL 85 85 46 68
CEFADROXIL 82 79 47 325
ALLOPURINOL 80 80 48 47
BISOPROLOL-HYDROCHLOROTHIAZIDE 80 80 48 240
SYNTHROID 79 79 50 93
CIPROFLOXACIN HCL 79 79 50 71
FLUTICASONE PROPIONATE 76 76 52 40
BONIVA 68 68 53 206
ESCITALOPRAM OXALATE 67 67 54 61
CLONIDINE HCL 65 65 55 52
MECLIZINE HCL 65 64 55 55
GLIPIZIDE-METFORMIN 64 64 57 371
EVISTA 63 63 58 257
DOXAZOSIN MESYLATE 60 60 59 73
GLIPIZIDE ER 55 55 60 107
GLYBURIDE 52 52 R 61 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.